<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00739752</url>
  </required_header>
  <id_info>
    <org_study_id>0205-04</org_study_id>
    <secondary_id>R01AI049644</secondary_id>
    <nct_id>NCT00739752</nct_id>
  </id_info>
  <brief_title>Interventions to Increase HBV Vaccinations in Sexually Transmitted Disease (STD) Clinics</brief_title>
  <official_title>Interventions to Increase HBV Vaccinations in STD Clinics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to evaluate two sets of interventions to increase acceptance of
      hepatitis B virus (HBV) vaccination in patients attending sexually transmitted disease (STD)
      clinics. The 1st set of interventions, with 3 levels, is based on message framing. The 3
      levels are: 1. information only; 2. gain-framed message; and 3. loss-framed message. The 2nd
      set of interventions, with 2 levels, involves how the vaccine is recommended by the health
      care provider. The 2 levels are: 1. HBV vaccine offered; and 2. HBV vaccine recommended. The
      outcome of interest is1st dose acceptance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of this study is to evaluate two sets of interventions to increase acceptance of
      hepatitis B virus (HBV) vaccination in patients attending sexually transmitted disease (STD)
      clinics. The 1st specific aim is to assess the effect of message-framing on vaccine
      acceptance. Framing theory suggests that positively framed messages (i.e., benefits of
      getting vaccine) are more effective than negatively framed messages (i.e., dangers of not
      getting vaccine) in stimulating preventive health behaviors. Research on Framing Theory and
      engagement in health behaviors suggests also that the effects may be moderated by other
      attitudinal factors, including perceived risk of the behavior and degree of involvement in
      the message. The 2nd aim is to evaluate the effect of provider-based interventions. Prior
      research suggests that recommendations by health providers are very important in patients'
      decisions regarding acceptance of health care procedures. Patients (18 years and older) will
      be recruited and followed from Chicago and Indianapolis STD clinics during routine medical
      visits. An audio computer-assisted self-interview (A-CASI) will cover demographics, risk
      behaviors, and perceived risk associated with vaccination. Subjects then will be randomized
      to receive a gain-framed, loss-framed, or information only message regarding HBV immunization
      (also delivered by A-CASI). Upon completion of the message-framing intervention, subjects
      will complete additional attitude questions via A-CASI. Upon completion of the A-CASI
      subjects will be randomly assigned to one of two provider intervention conditions: 1. vaccine
      offered or 2. vaccine recommended. For both conditions free HBV immunization will be provided
      by a nurse practitioner. Subsequently, postcard reminders will be sent and phone call
      reminders made for follow-up appointments for those receiving the first and second doses of
      vaccine. The primary outcome measure is HBV vaccination.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2003</start_date>
  <completion_date type="Actual">October 2007</completion_date>
  <primary_completion_date type="Actual">June 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>2 X 3 Factorial Design</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Administered Hepatitis B Vaccine</measure>
    <time_frame>Day of research visit</time_frame>
    <description>Number of participants administered hepatitis B vaccine on the day of research visit.</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">1747</enrollment>
  <condition>Hepatitis B Virus</condition>
  <arm_group>
    <arm_group_label>Non-Framed-Offered</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Non-Framed, Information Only Condition. Vaccine Offered.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Framed-Recommended</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Non-Framed, Information Only Condition. Vaccine Recommended.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gain-Framed-Offered</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Gain-Framed Intervention emphasizes the benefits associated with receiving HBV vaccine. Vaccine Offered.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gain-Framed-Recommended</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Gain-Framed Intervention emphasizes the benefits associated with receiving HBV vaccine. Vaccine Recommended.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Loss-Framed-Offered</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Loss-Framed Intervention emphasizes the risks associated with not receiving HBV vaccine. Vaccine Offered.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Loss-Framed-Recommended</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Loss-Framed Intervention emphasizes the risks associated with not receiving HBV vaccine. Vaccine Recommended.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Non-Framed-Offered</intervention_name>
    <description>Subjects received information only and are offered the vaccine.</description>
    <arm_group_label>Non-Framed-Offered</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Non-Framed-Recommended</intervention_name>
    <description>Subjects receive information only and are recommended the vaccine.</description>
    <arm_group_label>Non-Framed-Recommended</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Gain-Framed-Offered</intervention_name>
    <description>Subjects receive gain-framed messages and are offered the vaccine.</description>
    <arm_group_label>Gain-Framed-Offered</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Gain-Framed-Recommended</intervention_name>
    <description>Subjects receive gain-framed messages and are recommended the vaccine.</description>
    <arm_group_label>Gain-Framed-Recommended</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Loss-Framed-Offered</intervention_name>
    <description>Subjects receive loss-framed messages and are offered the vaccine.</description>
    <arm_group_label>Loss-Framed-Offered</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Loss-Framed-Recommended</intervention_name>
    <description>Subjects receive loss-framed messages and are recommended the vaccine.</description>
    <arm_group_label>Loss-Framed-Recommended</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 and older males and females

          -  No prior self-reported history of HBV immunization or infection

          -  Fluent in English

          -  Not known to be HIV positive.

        Exclusion Criteria:

          -  Under age 18

          -  Received any prior HBV vaccination

          -  Prior infection of Hepatitis B

          -  Unable to read or comprehend the English language

          -  HIV positive
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregory D Zimet, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chicago Department of Public Health</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bell Flower Clinic</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Cox AD, Cox D, Zimet G. Promoting prevention and early detection: The impact of message framing, product function and perceived product risk. J Marketing 2006;70:79-91.</citation>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2008</study_first_submitted>
  <study_first_submitted_qc>August 21, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2008</study_first_posted>
  <results_first_submitted>April 6, 2017</results_first_submitted>
  <results_first_submitted_qc>September 15, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">October 16, 2017</results_first_posted>
  <last_update_submitted>September 15, 2017</last_update_submitted>
  <last_update_submitted_qc>September 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University</investigator_affiliation>
    <investigator_full_name>Gregory Zimet</investigator_full_name>
    <investigator_title>Professor of Pediatrics &amp; Clinical Psychology</investigator_title>
  </responsible_party>
  <keyword>Attitude to Health</keyword>
  <keyword>Communication</keyword>
  <keyword>Intervention Studies</keyword>
  <keyword>Health Promotion</keyword>
  <keyword>Psychology, Medical</keyword>
  <keyword>Sexual Behavior</keyword>
  <keyword>Behavioral Research</keyword>
  <keyword>Vaccination</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis B</mesh_term>
    <mesh_term>Sexually Transmitted Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Non-Framed-Offered</title>
          <description>Non-Framed, Information Only Condition. Vaccine Offered.
Non-Framed-Offered: Subjects received information only and are offered the vaccine.</description>
        </group>
        <group group_id="P2">
          <title>Non-Framed-Recommended</title>
          <description>Non-Framed, Information Only Condition. Vaccine Recommended.
Non-Framed-Recommended: Subjects receive information only and are recommended the vaccine.</description>
        </group>
        <group group_id="P3">
          <title>Gain-Framed-Offered</title>
          <description>Gain-Framed Intervention emphasizes the benefits associated with receiving HBV vaccine. Vaccine Offered.
Gain-Framed-Offered: Subjects receive gain-framed messages and are offered the vaccine.</description>
        </group>
        <group group_id="P4">
          <title>Gain-Framed-Recommended</title>
          <description>Gain-Framed Intervention emphasizes the benefits associated with receiving HBV vaccine. Vaccine Recommended.
Gain-Framed-Recommended: Subjects receive gain-framed messages and are recommended the vaccine.</description>
        </group>
        <group group_id="P5">
          <title>Loss-Framed-Offered</title>
          <description>Loss-Framed Intervention emphasizes the risks associated with not receiving HBV vaccine. Vaccine Offered.
Loss-Framed-Offered: Subjects receive loss-framed messages and are offered the vaccine.</description>
        </group>
        <group group_id="P6">
          <title>Loss-Framed-Recommended</title>
          <description>Loss-Framed Intervention emphasizes the risks associated with not receiving HBV vaccine. Vaccine Recommended.
Loss-Framed-Recommended: Subjects receive loss-framed messages and are recommended the vaccine.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="299"/>
                <participants group_id="P2" count="284"/>
                <participants group_id="P3" count="292"/>
                <participants group_id="P4" count="288"/>
                <participants group_id="P5" count="291"/>
                <participants group_id="P6" count="293"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="299"/>
                <participants group_id="P2" count="284"/>
                <participants group_id="P3" count="292"/>
                <participants group_id="P4" count="288"/>
                <participants group_id="P5" count="291"/>
                <participants group_id="P6" count="293"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Non-Framed-Offered</title>
          <description>Non-Framed, Information Only Condition. Vaccine Offered.
Non-Framed-Offered: Subjects received information only and are offered the vaccine.</description>
        </group>
        <group group_id="B2">
          <title>Non-Framed-Recommended</title>
          <description>Non-Framed, Information Only Condition. Vaccine Recommended.
Non-Framed-Recommended: Subjects receive information only and are recommended the vaccine.</description>
        </group>
        <group group_id="B3">
          <title>Gain-Framed-Offered</title>
          <description>Gain-Framed Intervention emphasizes the benefits associated with receiving HBV vaccine. Vaccine Offered.
Gain-Framed-Offered: Subjects receive gain-framed messages and are offered the vaccine.</description>
        </group>
        <group group_id="B4">
          <title>Gain-Framed-Recommended</title>
          <description>Gain-Framed Intervention emphasizes the benefits associated with receiving HBV vaccine. Vaccine Recommended.
Gain-Framed-Recommended: Subjects receive gain-framed messages and are recommended the vaccine.</description>
        </group>
        <group group_id="B5">
          <title>Loss-Framed-Offered</title>
          <description>Loss-Framed Intervention emphasizes the risks associated with not receiving HBV vaccine. Vaccine Offered.
Loss-Framed-Offered: Subjects receive loss-framed messages and are offered the vaccine.</description>
        </group>
        <group group_id="B6">
          <title>Loss-Framed-Recommended</title>
          <description>Loss-Framed Intervention emphasizes the risks associated with not receiving HBV vaccine. Vaccine Recommended.
Loss-Framed-Recommended: Subjects receive loss-framed messages and are recommended the vaccine.</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="299"/>
            <count group_id="B2" value="284"/>
            <count group_id="B3" value="292"/>
            <count group_id="B4" value="288"/>
            <count group_id="B5" value="291"/>
            <count group_id="B6" value="293"/>
            <count group_id="B7" value="1747"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.2" spread="9.7"/>
                    <measurement group_id="B2" value="31.8" spread="9.8"/>
                    <measurement group_id="B3" value="31.2" spread="9.8"/>
                    <measurement group_id="B4" value="31.7" spread="9.4"/>
                    <measurement group_id="B5" value="32.1" spread="10.1"/>
                    <measurement group_id="B6" value="32.3" spread="10.6"/>
                    <measurement group_id="B7" value="31.7" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="178"/>
                    <measurement group_id="B2" value="179"/>
                    <measurement group_id="B3" value="175"/>
                    <measurement group_id="B4" value="166"/>
                    <measurement group_id="B5" value="179"/>
                    <measurement group_id="B6" value="177"/>
                    <measurement group_id="B7" value="1054"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="121"/>
                    <measurement group_id="B2" value="105"/>
                    <measurement group_id="B3" value="117"/>
                    <measurement group_id="B4" value="122"/>
                    <measurement group_id="B5" value="112"/>
                    <measurement group_id="B6" value="116"/>
                    <measurement group_id="B7" value="693"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="6"/>
                    <measurement group_id="B6" value="9"/>
                    <measurement group_id="B7" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="284"/>
                    <measurement group_id="B2" value="272"/>
                    <measurement group_id="B3" value="278"/>
                    <measurement group_id="B4" value="275"/>
                    <measurement group_id="B5" value="282"/>
                    <measurement group_id="B6" value="278"/>
                    <measurement group_id="B7" value="1669"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="6"/>
                    <measurement group_id="B7" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="252"/>
                    <measurement group_id="B2" value="233"/>
                    <measurement group_id="B3" value="239"/>
                    <measurement group_id="B4" value="233"/>
                    <measurement group_id="B5" value="236"/>
                    <measurement group_id="B6" value="233"/>
                    <measurement group_id="B7" value="1426"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="37"/>
                    <measurement group_id="B4" value="38"/>
                    <measurement group_id="B5" value="35"/>
                    <measurement group_id="B6" value="45"/>
                    <measurement group_id="B7" value="224"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="7"/>
                    <measurement group_id="B6" value="9"/>
                    <measurement group_id="B7" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="12"/>
                    <measurement group_id="B6" value="4"/>
                    <measurement group_id="B7" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="299"/>
                    <measurement group_id="B2" value="284"/>
                    <measurement group_id="B3" value="292"/>
                    <measurement group_id="B4" value="288"/>
                    <measurement group_id="B5" value="291"/>
                    <measurement group_id="B6" value="293"/>
                    <measurement group_id="B7" value="1747"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Administered Hepatitis B Vaccine</title>
        <description>Number of participants administered hepatitis B vaccine on the day of research visit.</description>
        <time_frame>Day of research visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Non-Framed-Offered</title>
            <description>Non-Framed, Information Only Condition. Vaccine Offered.
Non-Framed-Offered: Subjects received information only and are offered the vaccine.</description>
          </group>
          <group group_id="O2">
            <title>Non-Framed-Recommended</title>
            <description>Non-Framed, Information Only Condition. Vaccine Recommended.
Non-Framed-Recommended: Subjects receive information only and are recommended the vaccine.</description>
          </group>
          <group group_id="O3">
            <title>Gain-Framed-Offered</title>
            <description>Gain-Framed Intervention emphasizes the benefits associated with receiving HBV vaccine. Vaccine Offered.
Gain-Framed-Offered: Subjects receive gain-framed messages and are offered the vaccine.</description>
          </group>
          <group group_id="O4">
            <title>Gain-Framed-Recommended</title>
            <description>Gain-Framed Intervention emphasizes the benefits associated with receiving HBV vaccine. Vaccine Recommended.
Gain-Framed-Recommended: Subjects receive gain-framed messages and are recommended the vaccine.</description>
          </group>
          <group group_id="O5">
            <title>Loss-Framed-Offered</title>
            <description>Loss-Framed Intervention emphasizes the risks associated with not receiving HBV vaccine. Vaccine Offered.
Loss-Framed-Offered: Subjects receive loss-framed messages and are offered the vaccine.</description>
          </group>
          <group group_id="O6">
            <title>Loss-Framed-Recommended</title>
            <description>Loss-Framed Intervention emphasizes the risks associated with not receiving HBV vaccine. Vaccine Recommended.
Loss-Framed-Recommended: Subjects receive loss-framed messages and are recommended the vaccine.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Administered Hepatitis B Vaccine</title>
          <description>Number of participants administered hepatitis B vaccine on the day of research visit.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="299"/>
                <count group_id="O2" value="284"/>
                <count group_id="O3" value="292"/>
                <count group_id="O4" value="288"/>
                <count group_id="O5" value="291"/>
                <count group_id="O6" value="293"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140"/>
                    <measurement group_id="O2" value="146"/>
                    <measurement group_id="O3" value="150"/>
                    <measurement group_id="O4" value="166"/>
                    <measurement group_id="O5" value="139"/>
                    <measurement group_id="O6" value="173"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>The two gain-framed groups were compared to the two loss-framed groups using poisson regression.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.99</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.88</ci_lower_limit>
            <ci_upper_limit>1.12</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Groups receiving any framed interventions (gain-framed or loss-framed) were compared to those in the two non-framed control groups.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.17</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.06</ci_lower_limit>
            <ci_upper_limit>1.31</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>The 3 vaccine-recommended groups were compared with the 3 vaccine-offered groups using poisson regression.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.16</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.05</ci_lower_limit>
            <ci_upper_limit>1.28</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Non-Framed-Offered</title>
          <description>Non-Framed, Information Only Condition. Vaccine Offered.
Non-Framed-Offered: Subjects received information only and are offered the vaccine.</description>
        </group>
        <group group_id="E2">
          <title>Non-Framed-Recommended</title>
          <description>Non-Framed, Information Only Condition. Vaccine Recommended.
Non-Framed-Recommended: Subjects receive information only and are recommended the vaccine.</description>
        </group>
        <group group_id="E3">
          <title>Gain-Framed-Offered</title>
          <description>Gain-Framed Intervention emphasizes the benefits associated with receiving HBV vaccine. Vaccine Offered.
Gain-Framed-Offered: Subjects receive gain-framed messages and are offered the vaccine.</description>
        </group>
        <group group_id="E4">
          <title>Gain-Framed-Recommended</title>
          <description>Gain-Framed Intervention emphasizes the benefits associated with receiving HBV vaccine. Vaccine Recommended.
Gain-Framed-Recommended: Subjects receive gain-framed messages and are recommended the vaccine.</description>
        </group>
        <group group_id="E5">
          <title>Loss-Framed-Offered</title>
          <description>Loss-Framed Intervention emphasizes the risks associated with not receiving HBV vaccine. Vaccine Offered.
Loss-Framed-Offered: Subjects receive loss-framed messages and are offered the vaccine.</description>
        </group>
        <group group_id="E6">
          <title>Loss-Framed-Recommended</title>
          <description>Loss-Framed Intervention emphasizes the risks associated with not receiving HBV vaccine. Vaccine Recommended.
Loss-Framed-Recommended: Subjects receive loss-framed messages and are recommended the vaccine.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="284"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="292"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="288"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="291"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="293"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="284"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="292"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="288"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="291"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="293"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="284"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="292"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="288"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="291"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="293"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Gregory Zimet</name_or_title>
      <organization>Indiana University</organization>
      <phone>317-274-8812</phone>
      <email>gzimet@iu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

